

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.85648852 |
| 2 | mating behavior (GO:0007617) | 5.75015948 |
| 3 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 5.73403355 |
| 4 | glutamate secretion (GO:0014047) | 5.50558196 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.46698739 |
| 6 | vocalization behavior (GO:0071625) | 5.40863809 |
| 7 | presynaptic membrane assembly (GO:0097105) | 5.36773409 |
| 8 | synaptic vesicle exocytosis (GO:0016079) | 5.30742128 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.18596084 |
| 10 | neuronal action potential propagation (GO:0019227) | 5.15074252 |
| 11 | neuron cell-cell adhesion (GO:0007158) | 5.14277273 |
| 12 | postsynaptic membrane organization (GO:0001941) | 5.01694486 |
| 13 | dopamine transport (GO:0015872) | 4.99351262 |
| 14 | dopamine biosynthetic process (GO:0042416) | 4.95316306 |
| 15 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.93076045 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.93040348 |
| 17 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.90043157 |
| 18 | presynaptic membrane organization (GO:0097090) | 4.83309724 |
| 19 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.74703092 |
| 20 | protein localization to synapse (GO:0035418) | 4.51979607 |
| 21 | regulation of synaptic vesicle transport (GO:1902803) | 4.51784837 |
| 22 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.35555922 |
| 23 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 4.29625002 |
| 24 | neurotransmitter secretion (GO:0007269) | 4.17288404 |
| 25 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.06953937 |
| 26 | neuron-neuron synaptic transmission (GO:0007270) | 4.04929049 |
| 27 | synaptic vesicle maturation (GO:0016188) | 3.99739350 |
| 28 | catecholamine transport (GO:0051937) | 3.98323358 |
| 29 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.88749958 |
| 30 | synaptic transmission, glutamatergic (GO:0035249) | 3.86261842 |
| 31 | prepulse inhibition (GO:0060134) | 3.81904109 |
| 32 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.77480166 |
| 33 | potassium ion homeostasis (GO:0055075) | 3.76087069 |
| 34 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.71719211 |
| 35 | response to histamine (GO:0034776) | 3.66858035 |
| 36 | glutamate receptor signaling pathway (GO:0007215) | 3.62826503 |
| 37 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.61241172 |
| 38 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.59213883 |
| 39 | locomotory exploration behavior (GO:0035641) | 3.56889986 |
| 40 | gamma-aminobutyric acid transport (GO:0015812) | 3.56886574 |
| 41 | startle response (GO:0001964) | 3.56770780 |
| 42 | regulation of neurotransmitter secretion (GO:0046928) | 3.55108894 |
| 43 | cellular sodium ion homeostasis (GO:0006883) | 3.53867898 |
| 44 | long-term synaptic potentiation (GO:0060291) | 3.53847662 |
| 45 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.52371870 |
| 46 | mechanosensory behavior (GO:0007638) | 3.49733910 |
| 47 | synaptic vesicle endocytosis (GO:0048488) | 3.47276780 |
| 48 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.45658749 |
| 49 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.45571230 |
| 50 | response to auditory stimulus (GO:0010996) | 3.45387054 |
| 51 | neurotransmitter transport (GO:0006836) | 3.44125902 |
| 52 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.40238695 |
| 53 | sodium ion export (GO:0071436) | 3.38616190 |
| 54 | insulin secretion (GO:0030073) | 3.37915109 |
| 55 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.37027577 |
| 56 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.35253935 |
| 57 | positive regulation of neurotransmitter transport (GO:0051590) | 3.33587598 |
| 58 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.33337659 |
| 59 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.33204836 |
| 60 | serotonin receptor signaling pathway (GO:0007210) | 3.31587447 |
| 61 | positive regulation of membrane potential (GO:0045838) | 3.30880472 |
| 62 | proline transport (GO:0015824) | 3.29784432 |
| 63 | negative regulation of hormone metabolic process (GO:0032351) | 3.28971970 |
| 64 | protein prenylation (GO:0018342) | 3.28642667 |
| 65 | prenylation (GO:0097354) | 3.28642667 |
| 66 | phosphorelay signal transduction system (GO:0000160) | 3.28043249 |
| 67 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.27675080 |
| 68 | potassium ion import (GO:0010107) | 3.27519119 |
| 69 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.27448850 |
| 70 | urinary tract smooth muscle contraction (GO:0014848) | 3.27162392 |
| 71 | serotonin metabolic process (GO:0042428) | 3.26244756 |
| 72 | regulation of postsynaptic membrane potential (GO:0060078) | 3.24705008 |
| 73 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.23668012 |
| 74 | positive regulation of synapse assembly (GO:0051965) | 3.23550220 |
| 75 | regulation of neurotransmitter transport (GO:0051588) | 3.21115302 |
| 76 | auditory behavior (GO:0031223) | 3.17000207 |
| 77 | regulation of synapse maturation (GO:0090128) | 3.15474760 |
| 78 | long-term memory (GO:0007616) | 3.14660649 |
| 79 | catechol-containing compound biosynthetic process (GO:0009713) | 3.14135436 |
| 80 | catecholamine biosynthetic process (GO:0042423) | 3.14135436 |
| 81 | dendritic spine morphogenesis (GO:0060997) | 3.10464561 |
| 82 | membrane hyperpolarization (GO:0060081) | 3.07182634 |
| 83 | neuromuscular process controlling posture (GO:0050884) | 3.06343625 |
| 84 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.05645746 |
| 85 | response to insecticide (GO:0017085) | 3.05366288 |
| 86 | regulation of neurotransmitter levels (GO:0001505) | 3.04611942 |
| 87 | opioid receptor signaling pathway (GO:0038003) | 3.04275829 |
| 88 | positive regulation of synapse maturation (GO:0090129) | 3.03516699 |
| 89 | chemosensory behavior (GO:0007635) | 3.03090234 |
| 90 | cerebellar granule cell differentiation (GO:0021707) | 3.02283782 |
| 91 | inositol phosphate-mediated signaling (GO:0048016) | 3.00777215 |
| 92 | righting reflex (GO:0060013) | 3.00189847 |
| 93 | regulation of vesicle fusion (GO:0031338) | 2.99848192 |
| 94 | regulation of synaptic plasticity (GO:0048167) | 2.99736266 |
| 95 | negative regulation of neurotransmitter transport (GO:0051589) | 2.99666801 |
| 96 | transferrin transport (GO:0033572) | 2.98735941 |
| 97 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.98726930 |
| 98 | potassium ion transport (GO:0006813) | 2.98178068 |
| 99 | synaptic transmission (GO:0007268) | 2.98076285 |
| 100 | regulation of dopamine metabolic process (GO:0042053) | 2.97042599 |
| 101 | regulation of catecholamine metabolic process (GO:0042069) | 2.97042599 |
| 102 | response to amphetamine (GO:0001975) | 2.96340695 |
| 103 | positive regulation of synaptic transmission (GO:0050806) | 2.95795208 |
| 104 | regulation of synapse assembly (GO:0051963) | 2.94323927 |
| 105 | membrane depolarization during action potential (GO:0086010) | 2.94193804 |
| 106 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.93318489 |
| 107 | cellular ketone body metabolic process (GO:0046950) | 2.90988554 |
| 108 | neurotransmitter biosynthetic process (GO:0042136) | 2.88963530 |
| 109 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.87394767 |
| 110 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.87040797 |
| 111 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.87040797 |
| 112 | retinal cone cell development (GO:0046549) | 2.85025921 |
| 113 | neuronal action potential (GO:0019228) | 2.84853492 |
| 114 | membrane depolarization (GO:0051899) | 2.83412323 |
| 115 | detection of calcium ion (GO:0005513) | 2.82462026 |
| 116 | signal release (GO:0023061) | 2.82320498 |
| 117 | negative regulation of dendrite development (GO:2000171) | 2.79508067 |
| 118 | cellular potassium ion homeostasis (GO:0030007) | 2.79125338 |
| 119 | synaptic vesicle transport (GO:0048489) | 2.78675504 |
| 120 | establishment of synaptic vesicle localization (GO:0097480) | 2.78675504 |
| 121 | behavioral response to cocaine (GO:0048148) | 2.78468072 |
| 122 | ferric iron transport (GO:0015682) | 2.77971514 |
| 123 | trivalent inorganic cation transport (GO:0072512) | 2.77971514 |
| 124 | primary amino compound metabolic process (GO:1901160) | 2.77047347 |
| 125 | glycerophospholipid catabolic process (GO:0046475) | 2.76882080 |
| 126 | regulation of respiratory system process (GO:0044065) | 2.76630143 |
| 127 | regulation of glucokinase activity (GO:0033131) | 2.75163455 |
| 128 | regulation of hexokinase activity (GO:1903299) | 2.75163455 |
| 129 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.74975287 |
| 130 | auditory receptor cell stereocilium organization (GO:0060088) | 2.74644318 |
| 131 | exploration behavior (GO:0035640) | 2.74330102 |
| 132 | potassium ion transmembrane transport (GO:0071805) | 2.73605698 |
| 133 | cellular potassium ion transport (GO:0071804) | 2.73605698 |
| 134 | adult walking behavior (GO:0007628) | 2.73248568 |
| 135 | regulation of synaptic transmission (GO:0050804) | 2.71286113 |
| 136 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.70817180 |
| 137 | neuromuscular synaptic transmission (GO:0007274) | 2.70669348 |
| 138 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.70639000 |
| 139 | neuron recognition (GO:0008038) | 2.70051268 |
| 140 | calcium ion-dependent exocytosis (GO:0017156) | 2.67504190 |
| 141 | transmission of nerve impulse (GO:0019226) | 2.66982021 |
| 142 | learning (GO:0007612) | 2.64902376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.29284017 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.65486872 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.54910946 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.92886150 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.76697712 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.75475054 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.72893608 |
| 8 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.71002605 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.57370634 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.48145677 |
| 11 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.41694245 |
| 12 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.34500925 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.31979310 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.31979310 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.30891777 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.28730242 |
| 17 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.28474598 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.27388998 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.26695836 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.26211163 |
| 21 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.22068978 |
| 22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.08880883 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.06795143 |
| 24 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.04163712 |
| 25 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.03382960 |
| 26 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.02710921 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.01300073 |
| 28 | P300_19829295_ChIP-Seq_ESCs_Human | 1.98221685 |
| 29 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.93367698 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.92559966 |
| 31 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.88322558 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.85008251 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.82938833 |
| 34 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.80892378 |
| 35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.79115542 |
| 36 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.78861786 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.76788527 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.75996080 |
| 39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.69412706 |
| 40 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.65420034 |
| 41 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.64618671 |
| 42 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.63720926 |
| 43 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.60861598 |
| 44 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.57695306 |
| 45 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.57640719 |
| 46 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.55619905 |
| 47 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.53893656 |
| 48 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.53236259 |
| 49 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.51875559 |
| 50 | AR_25329375_ChIP-Seq_VCAP_Human | 1.48294586 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.48062651 |
| 52 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.44900794 |
| 53 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.44293724 |
| 54 | FUS_26573619_Chip-Seq_HEK293_Human | 1.41645772 |
| 55 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.41382166 |
| 56 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.40745716 |
| 57 | VDR_22108803_ChIP-Seq_LS180_Human | 1.40587693 |
| 58 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.39481688 |
| 59 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.38266311 |
| 60 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.37403686 |
| 61 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37391425 |
| 62 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.37350373 |
| 63 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35357215 |
| 64 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.34228422 |
| 65 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.34135278 |
| 66 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.32902325 |
| 67 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.31813739 |
| 68 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.31508263 |
| 69 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.30583439 |
| 70 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.29345384 |
| 71 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.28312722 |
| 72 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26283840 |
| 73 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.25491641 |
| 74 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25406554 |
| 75 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.25335626 |
| 76 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21959908 |
| 77 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21400125 |
| 78 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21400125 |
| 79 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.20629662 |
| 80 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.20516440 |
| 81 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.20515473 |
| 82 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.19855020 |
| 83 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19822403 |
| 84 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.19170813 |
| 85 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.19010296 |
| 86 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.18631551 |
| 87 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18584333 |
| 88 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.16926090 |
| 89 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.15903664 |
| 90 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.14661529 |
| 91 | JUN_21703547_ChIP-Seq_K562_Human | 1.14119123 |
| 92 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.13695479 |
| 93 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.13567665 |
| 94 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.13567665 |
| 95 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.13307708 |
| 96 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.11928378 |
| 97 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11260335 |
| 98 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10921344 |
| 99 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09443982 |
| 100 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.08742155 |
| 101 | KDM2B_26808549_Chip-Seq_REH_Human | 1.08166027 |
| 102 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07771861 |
| 103 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07303175 |
| 104 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07166681 |
| 105 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.06830625 |
| 106 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.06382692 |
| 107 | TP53_16413492_ChIP-PET_HCT116_Human | 1.06200310 |
| 108 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.06072596 |
| 109 | AR_19668381_ChIP-Seq_PC3_Human | 1.05565975 |
| 110 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05547533 |
| 111 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.05401586 |
| 112 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.05183563 |
| 113 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.04530432 |
| 114 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04407626 |
| 115 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.02738641 |
| 116 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01650598 |
| 117 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01250862 |
| 118 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.01106468 |
| 119 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00831890 |
| 120 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.00395011 |
| 121 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00388907 |
| 122 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.99926393 |
| 123 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97694948 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 5.56601646 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.77478161 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 3.57496425 |
| 4 | MP0009046_muscle_twitch | 3.55679535 |
| 5 | MP0009745_abnormal_behavioral_response | 3.42638858 |
| 6 | MP0001968_abnormal_touch/_nociception | 3.41226741 |
| 7 | MP0002064_seizures | 3.06300114 |
| 8 | MP0003123_paternal_imprinting | 3.03286121 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.82989228 |
| 10 | MP0004270_analgesia | 2.81157567 |
| 11 | MP0002735_abnormal_chemical_nociception | 2.80910970 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.75581154 |
| 13 | MP0002736_abnormal_nociception_after | 2.70543222 |
| 14 | MP0001486_abnormal_startle_reflex | 2.61456557 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.57615512 |
| 16 | MP0002272_abnormal_nervous_system | 2.57213094 |
| 17 | MP0002734_abnormal_mechanical_nocicepti | 2.50892108 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.50816597 |
| 19 | MP0003787_abnormal_imprinting | 2.48461023 |
| 20 | MP0001188_hyperpigmentation | 2.47369463 |
| 21 | MP0005646_abnormal_pituitary_gland | 2.41127488 |
| 22 | MP0002067_abnormal_sensory_capabilities | 2.24383367 |
| 23 | MP0003879_abnormal_hair_cell | 2.03662777 |
| 24 | MP0006276_abnormal_autonomic_nervous | 1.98015261 |
| 25 | MP0003283_abnormal_digestive_organ | 1.96089115 |
| 26 | MP0001440_abnormal_grooming_behavior | 1.93786153 |
| 27 | MP0001986_abnormal_taste_sensitivity | 1.89701088 |
| 28 | MP0002557_abnormal_social/conspecific_i | 1.86564220 |
| 29 | MP0001970_abnormal_pain_threshold | 1.85967997 |
| 30 | MP0002733_abnormal_thermal_nociception | 1.80027690 |
| 31 | MP0004924_abnormal_behavior | 1.75796034 |
| 32 | MP0005386_behavior/neurological_phenoty | 1.75796034 |
| 33 | MP0010386_abnormal_urinary_bladder | 1.71632730 |
| 34 | MP0004142_abnormal_muscle_tone | 1.70802874 |
| 35 | MP0001502_abnormal_circadian_rhythm | 1.68183291 |
| 36 | MP0003195_calcinosis | 1.67244637 |
| 37 | MP0002184_abnormal_innervation | 1.66177435 |
| 38 | MP0005171_absent_coat_pigmentation | 1.66130685 |
| 39 | MP0001984_abnormal_olfaction | 1.59775664 |
| 40 | MP0005645_abnormal_hypothalamus_physiol | 1.58637022 |
| 41 | MP0000013_abnormal_adipose_tissue | 1.55846647 |
| 42 | MP0003122_maternal_imprinting | 1.55226898 |
| 43 | MP0004742_abnormal_vestibular_system | 1.53980359 |
| 44 | MP0008569_lethality_at_weaning | 1.50934387 |
| 45 | MP0002876_abnormal_thyroid_physiology | 1.42820920 |
| 46 | MP0001905_abnormal_dopamine_level | 1.34960963 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 1.34181579 |
| 48 | MP0000778_abnormal_nervous_system | 1.33852558 |
| 49 | MP0004858_abnormal_nervous_system | 1.33219099 |
| 50 | MP0001944_abnormal_pancreas_morphology | 1.32864046 |
| 51 | MP0002693_abnormal_pancreas_physiology | 1.31033174 |
| 52 | MP0004811_abnormal_neuron_physiology | 1.30963560 |
| 53 | MP0003646_muscle_fatigue | 1.29335915 |
| 54 | MP0006292_abnormal_olfactory_placode | 1.29228625 |
| 55 | MP0008004_abnormal_stomach_pH | 1.26904134 |
| 56 | MP0001963_abnormal_hearing_physiology | 1.24662700 |
| 57 | MP0002066_abnormal_motor_capabilities/c | 1.22219943 |
| 58 | MP0000015_abnormal_ear_pigmentation | 1.17761863 |
| 59 | MP0003690_abnormal_glial_cell | 1.16543916 |
| 60 | MP0003633_abnormal_nervous_system | 1.14181755 |
| 61 | MP0002882_abnormal_neuron_morphology | 1.12491011 |
| 62 | MP0002638_abnormal_pupillary_reflex | 1.11991577 |
| 63 | MP0000955_abnormal_spinal_cord | 1.09464556 |
| 64 | MP0005551_abnormal_eye_electrophysiolog | 1.09159329 |
| 65 | MP0001529_abnormal_vocalization | 1.08918424 |
| 66 | MP0001485_abnormal_pinna_reflex | 1.05943274 |
| 67 | MP0002822_catalepsy | 1.05251412 |
| 68 | MP0000569_abnormal_digit_pigmentation | 1.04321337 |
| 69 | MP0004215_abnormal_myocardial_fiber | 0.97960691 |
| 70 | MP0010234_abnormal_vibrissa_follicle | 0.96987750 |
| 71 | MP0000631_abnormal_neuroendocrine_gland | 0.95842187 |
| 72 | MP0002102_abnormal_ear_morphology | 0.93388464 |
| 73 | MP0002078_abnormal_glucose_homeostasis | 0.89376915 |
| 74 | MP0003631_nervous_system_phenotype | 0.88005006 |
| 75 | MP0001664_abnormal_digestion | 0.87141328 |
| 76 | MP0002229_neurodegeneration | 0.86734199 |
| 77 | MP0003045_fibrosis | 0.85435492 |
| 78 | MP0002909_abnormal_adrenal_gland | 0.84135529 |
| 79 | MP0001177_atelectasis | 0.84046823 |
| 80 | MP0001765_abnormal_ion_homeostasis | 0.83402034 |
| 81 | MP0004885_abnormal_endolymph | 0.81874888 |
| 82 | MP0000639_abnormal_adrenal_gland | 0.81158721 |
| 83 | MP0008872_abnormal_physiological_respon | 0.80628111 |
| 84 | MP0008877_abnormal_DNA_methylation | 0.80559877 |
| 85 | MP0000003_abnormal_adipose_tissue | 0.79289004 |
| 86 | MP0010329_abnormal_lipoprotein_level | 0.78741022 |
| 87 | MP0005377_hearing/vestibular/ear_phenot | 0.78619675 |
| 88 | MP0003878_abnormal_ear_physiology | 0.78619675 |
| 89 | MP0000920_abnormal_myelination | 0.77912013 |
| 90 | MP0003953_abnormal_hormone_level | 0.77317641 |
| 91 | MP0005220_abnormal_exocrine_pancreas | 0.76817619 |
| 92 | MP0000026_abnormal_inner_ear | 0.76710467 |
| 93 | MP0003632_abnormal_nervous_system | 0.76082341 |
| 94 | MP0000427_abnormal_hair_cycle | 0.75417951 |
| 95 | MP0008874_decreased_physiological_sensi | 0.75101099 |
| 96 | MP0005409_darkened_coat_color | 0.75029577 |
| 97 | MP0005448_abnormal_energy_balance | 0.74394007 |
| 98 | MP0004484_altered_response_of | 0.73515138 |
| 99 | MP0001756_abnormal_urination | 0.72491847 |
| 100 | MP0002163_abnormal_gland_morphology | 0.72482338 |
| 101 | MP0004043_abnormal_pH_regulation | 0.72032128 |
| 102 | MP0005535_abnormal_body_temperature | 0.71656908 |
| 103 | MP0002837_dystrophic_cardiac_calcinosis | 0.71313282 |
| 104 | MP0002160_abnormal_reproductive_system | 0.71003776 |
| 105 | MP0006072_abnormal_retinal_apoptosis | 0.70239682 |
| 106 | MP0002069_abnormal_eating/drinking_beha | 0.70176957 |
| 107 | MP0005410_abnormal_fertilization | 0.69676122 |
| 108 | MP0005253_abnormal_eye_physiology | 0.68799271 |
| 109 | MP0002152_abnormal_brain_morphology | 0.68761393 |
| 110 | MP0002752_abnormal_somatic_nervous | 0.67971523 |
| 111 | MP0003121_genomic_imprinting | 0.67189301 |
| 112 | MP0003136_yellow_coat_color | 0.65986114 |
| 113 | MP0000681_abnormal_thyroid_gland | 0.65230437 |
| 114 | MP0008260_abnormal_autophagy | 0.62976664 |
| 115 | MP0010678_abnormal_skin_adnexa | 0.62158384 |
| 116 | MP0004085_abnormal_heartbeat | 0.61462799 |
| 117 | MP0005379_endocrine/exocrine_gland_phen | 0.60694884 |
| 118 | MP0002090_abnormal_vision | 0.60188062 |
| 119 | MP0003172_abnormal_lysosome_physiology | 0.59242518 |
| 120 | MP0002277_abnormal_respiratory_mucosa | 0.59071453 |
| 121 | MP0004145_abnormal_muscle_electrophysio | 0.58763289 |
| 122 | MP0003329_amyloid_beta_deposits | 0.58524584 |
| 123 | MP0000751_myopathy | 0.53967158 |
| 124 | MP0005499_abnormal_olfactory_system | 0.52629313 |
| 125 | MP0005394_taste/olfaction_phenotype | 0.52629313 |
| 126 | MP0003183_abnormal_peptide_metabolism | 0.52452228 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 9.45138154 |
| 2 | Febrile seizures (HP:0002373) | 6.70915745 |
| 3 | Epileptic encephalopathy (HP:0200134) | 6.38316539 |
| 4 | Atonic seizures (HP:0010819) | 5.98010103 |
| 5 | Focal seizures (HP:0007359) | 5.29680070 |
| 6 | Hyperventilation (HP:0002883) | 4.90723317 |
| 7 | Absence seizures (HP:0002121) | 4.53948804 |
| 8 | Myokymia (HP:0002411) | 4.45121863 |
| 9 | Ketoacidosis (HP:0001993) | 4.30909667 |
| 10 | Hypokinesia (HP:0002375) | 4.18471859 |
| 11 | Dialeptic seizures (HP:0011146) | 4.05659463 |
| 12 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.05305679 |
| 13 | Progressive cerebellar ataxia (HP:0002073) | 3.90784523 |
| 14 | Hyperglycemia (HP:0003074) | 3.88804963 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 3.78880022 |
| 16 | Hypoglycemic seizures (HP:0002173) | 3.77385545 |
| 17 | Fetal akinesia sequence (HP:0001989) | 3.41118581 |
| 18 | Broad-based gait (HP:0002136) | 3.39578124 |
| 19 | Large for gestational age (HP:0001520) | 3.36300683 |
| 20 | Diminished movement (HP:0002374) | 3.33079832 |
| 21 | Supranuclear gaze palsy (HP:0000605) | 3.25699686 |
| 22 | Gaze-evoked nystagmus (HP:0000640) | 3.25082340 |
| 23 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.20208835 |
| 24 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.20208835 |
| 25 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.09776199 |
| 26 | Poor eye contact (HP:0000817) | 3.08581416 |
| 27 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.06695186 |
| 28 | Absent/shortened dynein arms (HP:0200106) | 3.06695186 |
| 29 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.05360570 |
| 30 | Visual hallucinations (HP:0002367) | 3.03475125 |
| 31 | Nuclear cataract (HP:0100018) | 3.03466287 |
| 32 | Akinesia (HP:0002304) | 2.99798792 |
| 33 | Hypoglycemic coma (HP:0001325) | 2.97870783 |
| 34 | Inability to walk (HP:0002540) | 2.92744267 |
| 35 | Ventricular fibrillation (HP:0001663) | 2.83111485 |
| 36 | Intention tremor (HP:0002080) | 2.81662801 |
| 37 | Blue irides (HP:0000635) | 2.80969385 |
| 38 | Protruding tongue (HP:0010808) | 2.78951545 |
| 39 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.78135909 |
| 40 | Amblyopia (HP:0000646) | 2.77428541 |
| 41 | Zonular cataract (HP:0010920) | 2.76654143 |
| 42 | Abnormal hair whorl (HP:0010721) | 2.69967261 |
| 43 | Torticollis (HP:0000473) | 2.67399359 |
| 44 | Increased circulating renin level (HP:0000848) | 2.66528238 |
| 45 | Ketosis (HP:0001946) | 2.65630705 |
| 46 | Metaphyseal dysplasia (HP:0100255) | 2.62985856 |
| 47 | Abnormal eating behavior (HP:0100738) | 2.60849418 |
| 48 | Postural tremor (HP:0002174) | 2.60056869 |
| 49 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.59993312 |
| 50 | Generalized hypopigmentation of hair (HP:0011358) | 2.59751521 |
| 51 | Chronic hepatic failure (HP:0100626) | 2.56420746 |
| 52 | Papilledema (HP:0001085) | 2.55185334 |
| 53 | Muscular hypotonia of the trunk (HP:0008936) | 2.54008410 |
| 54 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.52324645 |
| 55 | Agitation (HP:0000713) | 2.51268316 |
| 56 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.48978066 |
| 57 | Pheochromocytoma (HP:0002666) | 2.47668364 |
| 58 | Impaired social interactions (HP:0000735) | 2.41705841 |
| 59 | Abnormal social behavior (HP:0012433) | 2.41705841 |
| 60 | Menstrual irregularities (HP:0000858) | 2.41578288 |
| 61 | Scanning speech (HP:0002168) | 2.41210763 |
| 62 | Abnormality of saccadic eye movements (HP:0000570) | 2.41194486 |
| 63 | Absent eyebrow (HP:0002223) | 2.40301663 |
| 64 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.38861145 |
| 65 | Rigidity (HP:0002063) | 2.37011303 |
| 66 | Focal dystonia (HP:0004373) | 2.34475976 |
| 67 | Epileptiform EEG discharges (HP:0011182) | 2.27947625 |
| 68 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.26937728 |
| 69 | Cerebral hypomyelination (HP:0006808) | 2.26779024 |
| 70 | Medial flaring of the eyebrow (HP:0010747) | 2.25982778 |
| 71 | Congenital primary aphakia (HP:0007707) | 2.25187356 |
| 72 | Polyphagia (HP:0002591) | 2.23576698 |
| 73 | Truncal ataxia (HP:0002078) | 2.23201953 |
| 74 | Neuroendocrine neoplasm (HP:0100634) | 2.21844112 |
| 75 | Poor suck (HP:0002033) | 2.21525532 |
| 76 | Status epilepticus (HP:0002133) | 2.20912115 |
| 77 | Nephrogenic diabetes insipidus (HP:0009806) | 2.20794235 |
| 78 | Mutism (HP:0002300) | 2.19501766 |
| 79 | Gait imbalance (HP:0002141) | 2.18716901 |
| 80 | Drooling (HP:0002307) | 2.18706084 |
| 81 | Excessive salivation (HP:0003781) | 2.18706084 |
| 82 | Symptomatic seizures (HP:0011145) | 2.18411409 |
| 83 | Hyperthyroidism (HP:0000836) | 2.17337235 |
| 84 | Syncope (HP:0001279) | 2.15262328 |
| 85 | Dysdiadochokinesis (HP:0002075) | 2.14330520 |
| 86 | Hypothermia (HP:0002045) | 2.07738400 |
| 87 | Progressive inability to walk (HP:0002505) | 2.07238297 |
| 88 | Decreased central vision (HP:0007663) | 2.06983484 |
| 89 | Abnormal ciliary motility (HP:0012262) | 2.05393600 |
| 90 | Horizontal nystagmus (HP:0000666) | 2.05187332 |
| 91 | Craniofacial dystonia (HP:0012179) | 2.04579658 |
| 92 | Prominent metopic ridge (HP:0005487) | 2.03886338 |
| 93 | Hemiparesis (HP:0001269) | 2.03610263 |
| 94 | Limb dystonia (HP:0002451) | 2.03066409 |
| 95 | Iris hypopigmentation (HP:0007730) | 2.02929365 |
| 96 | EEG with generalized epileptiform discharges (HP:0011198) | 2.01221488 |
| 97 | Pancreatic fibrosis (HP:0100732) | 1.98319360 |
| 98 | Dysmetric saccades (HP:0000641) | 1.96087802 |
| 99 | Bundle branch block (HP:0011710) | 1.95540268 |
| 100 | Narrow nasal bridge (HP:0000446) | 1.93976528 |
| 101 | Absent speech (HP:0001344) | 1.93940068 |
| 102 | Fair hair (HP:0002286) | 1.93265808 |
| 103 | Corneal dystrophy (HP:0001131) | 1.92157062 |
| 104 | Diplopia (HP:0000651) | 1.91736446 |
| 105 | Abnormality of binocular vision (HP:0011514) | 1.91736446 |
| 106 | Stereotypic behavior (HP:0000733) | 1.91061301 |
| 107 | Anxiety (HP:0000739) | 1.90982434 |
| 108 | Generalized hypopigmentation (HP:0007513) | 1.90441387 |
| 109 | Impaired vibratory sensation (HP:0002495) | 1.89346001 |
| 110 | Enlarged penis (HP:0000040) | 1.87412003 |
| 111 | Ankle clonus (HP:0011448) | 1.86265334 |
| 112 | Hypomagnesemia (HP:0002917) | 1.84722312 |
| 113 | Ulnar claw (HP:0001178) | 1.83323719 |
| 114 | Impaired smooth pursuit (HP:0007772) | 1.82672177 |
| 115 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.81572239 |
| 116 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.81572239 |
| 117 | Absent eyelashes (HP:0000561) | 1.81320160 |
| 118 | Abnormal EKG (HP:0003115) | 1.80596145 |
| 119 | Tetraplegia (HP:0002445) | 1.80446712 |
| 120 | Delusions (HP:0000746) | 1.79286361 |
| 121 | Action tremor (HP:0002345) | 1.78329463 |
| 122 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.78180328 |
| 123 | Generalized myoclonic seizures (HP:0002123) | 1.77699077 |
| 124 | Submucous cleft hard palate (HP:0000176) | 1.77296420 |
| 125 | Dysmetria (HP:0001310) | 1.76976447 |
| 126 | Incomplete penetrance (HP:0003829) | 1.75939849 |
| 127 | Delayed gross motor development (HP:0002194) | 1.73905161 |
| 128 | Optic nerve hypoplasia (HP:0000609) | 1.73725033 |
| 129 | Hemiplegia (HP:0002301) | 1.72701844 |
| 130 | Dyskinesia (HP:0100660) | 1.72583010 |
| 131 | Prolonged QT interval (HP:0001657) | 1.72578792 |
| 132 | Abnormality of salivation (HP:0100755) | 1.72194418 |
| 133 | Hypsarrhythmia (HP:0002521) | 1.72154594 |
| 134 | Hypercortisolism (HP:0001578) | 1.70524904 |
| 135 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.70480691 |
| 136 | Abnormality of the metopic suture (HP:0005556) | 1.70354191 |
| 137 | Molar tooth sign on MRI (HP:0002419) | 1.70228579 |
| 138 | Abnormality of midbrain morphology (HP:0002418) | 1.70228579 |
| 139 | Depression (HP:0000716) | 1.69003949 |
| 140 | Abnormality of dental color (HP:0011073) | 1.68768711 |
| 141 | Failure to thrive in infancy (HP:0001531) | 1.68176918 |
| 142 | Postural instability (HP:0002172) | 1.67850616 |
| 143 | Hip dysplasia (HP:0001385) | 1.67785323 |
| 144 | True hermaphroditism (HP:0010459) | 1.67138969 |
| 145 | Specific learning disability (HP:0001328) | 1.66947253 |
| 146 | Osteomalacia (HP:0002749) | 1.61518031 |
| 147 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.60936050 |
| 148 | Genital tract atresia (HP:0001827) | 1.60480104 |
| 149 | Bradykinesia (HP:0002067) | 1.58289255 |
| 150 | Spinal canal stenosis (HP:0003416) | 1.57508086 |
| 151 | Sleep apnea (HP:0010535) | 1.57068459 |
| 152 | Thickened helices (HP:0000391) | 1.56753201 |
| 153 | Abnormality of the labia minora (HP:0012880) | 1.55954848 |
| 154 | Urinary urgency (HP:0000012) | 1.54543416 |
| 155 | Nonprogressive disorder (HP:0003680) | 1.53705551 |
| 156 | Vaginal atresia (HP:0000148) | 1.53621242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.79446604 |
| 2 | FRK | 3.96895653 |
| 3 | NTRK3 | 3.85546103 |
| 4 | MAP2K7 | 3.63268125 |
| 5 | EPHA4 | 3.43614138 |
| 6 | AKT3 | 3.06854415 |
| 7 | MAP3K4 | 2.97148612 |
| 8 | SIK3 | 2.96574828 |
| 9 | MAP3K12 | 2.94772482 |
| 10 | TNIK | 2.73499367 |
| 11 | CCNB1 | 2.67153727 |
| 12 | DAPK2 | 2.42927504 |
| 13 | PLK2 | 2.06897563 |
| 14 | PRPF4B | 1.92426798 |
| 15 | MAP2K4 | 1.88133287 |
| 16 | CAMKK2 | 1.69518805 |
| 17 | CDK19 | 1.69410248 |
| 18 | MAPK13 | 1.66102791 |
| 19 | CSNK1G3 | 1.66035766 |
| 20 | MINK1 | 1.63966992 |
| 21 | TRPM7 | 1.61348854 |
| 22 | CSNK1G1 | 1.54388683 |
| 23 | DAPK1 | 1.51160177 |
| 24 | PAK6 | 1.50149905 |
| 25 | MARK1 | 1.47185644 |
| 26 | SGK2 | 1.45430670 |
| 27 | MKNK2 | 1.45052271 |
| 28 | MAP3K9 | 1.43674221 |
| 29 | RIPK4 | 1.42823776 |
| 30 | TNK2 | 1.40248546 |
| 31 | CAMK1G | 1.39655885 |
| 32 | FGFR2 | 1.25370711 |
| 33 | NTRK2 | 1.24679069 |
| 34 | SIK2 | 1.24099312 |
| 35 | MAP3K2 | 1.19381684 |
| 36 | CDK3 | 1.19196884 |
| 37 | CAMKK1 | 1.14465604 |
| 38 | MAP4K2 | 1.14090035 |
| 39 | MUSK | 1.13002817 |
| 40 | BMPR2 | 1.12730104 |
| 41 | ADRBK2 | 1.09358448 |
| 42 | MAPKAPK5 | 1.09092988 |
| 43 | SGK494 | 1.07338143 |
| 44 | SGK223 | 1.07338143 |
| 45 | BRAF | 1.04034543 |
| 46 | PRKCG | 1.02912340 |
| 47 | GRK5 | 1.00538999 |
| 48 | OXSR1 | 0.98002968 |
| 49 | CAMK2A | 0.97350249 |
| 50 | CDK5 | 0.96810228 |
| 51 | MAPK7 | 0.95857605 |
| 52 | SGK3 | 0.89394178 |
| 53 | PINK1 | 0.89333878 |
| 54 | STK38 | 0.87845332 |
| 55 | PDK1 | 0.86627523 |
| 56 | STK16 | 0.85977185 |
| 57 | MAP2K6 | 0.81123090 |
| 58 | MAP3K13 | 0.80426324 |
| 59 | MAPK12 | 0.79066310 |
| 60 | BMPR1B | 0.78591509 |
| 61 | PRKCE | 0.78579568 |
| 62 | TXK | 0.78051592 |
| 63 | WNK4 | 0.76189859 |
| 64 | STK38L | 0.75726329 |
| 65 | CAMK1 | 0.74742194 |
| 66 | STK39 | 0.73199605 |
| 67 | SGK1 | 0.69438831 |
| 68 | FES | 0.69294013 |
| 69 | PTK2B | 0.68996075 |
| 70 | PIK3CG | 0.67549697 |
| 71 | BCR | 0.64239909 |
| 72 | PRKAA1 | 0.63274902 |
| 73 | STK11 | 0.62259320 |
| 74 | PRKCH | 0.61814967 |
| 75 | KSR1 | 0.61771526 |
| 76 | FGFR3 | 0.61224989 |
| 77 | NEK6 | 0.61090423 |
| 78 | NTRK1 | 0.61078596 |
| 79 | GRK7 | 0.59007279 |
| 80 | PDPK1 | 0.57206031 |
| 81 | MAP3K5 | 0.56555600 |
| 82 | PDK2 | 0.55060139 |
| 83 | TIE1 | 0.54609691 |
| 84 | INSRR | 0.54601056 |
| 85 | RPS6KA3 | 0.53346512 |
| 86 | WNK1 | 0.52680958 |
| 87 | CSNK1A1L | 0.51893864 |
| 88 | CDK8 | 0.51592236 |
| 89 | MAP3K11 | 0.51363511 |
| 90 | ZAK | 0.50033813 |
| 91 | FER | 0.49579156 |
| 92 | IRAK2 | 0.49137041 |
| 93 | ARAF | 0.49092673 |
| 94 | PRKD3 | 0.47060760 |
| 95 | CAMK2B | 0.46217711 |
| 96 | CSNK1A1 | 0.45719905 |
| 97 | YES1 | 0.45234027 |
| 98 | HIPK2 | 0.44827459 |
| 99 | PRKCA | 0.44558744 |
| 100 | CSNK1D | 0.44514855 |
| 101 | ADRBK1 | 0.43480826 |
| 102 | LMTK2 | 0.43151311 |
| 103 | LATS2 | 0.40965997 |
| 104 | CDK11A | 0.40853796 |
| 105 | CDK18 | 0.40162884 |
| 106 | PDK3 | 0.39106412 |
| 107 | PDK4 | 0.39106412 |
| 108 | WNK3 | 0.38953591 |
| 109 | PNCK | 0.38519394 |
| 110 | MKNK1 | 0.37275497 |
| 111 | ERBB3 | 0.36968737 |
| 112 | UHMK1 | 0.36938106 |
| 113 | LIMK1 | 0.36764974 |
| 114 | PASK | 0.36169160 |
| 115 | KSR2 | 0.35794386 |
| 116 | MAP2K1 | 0.35744168 |
| 117 | PRKG1 | 0.35536707 |
| 118 | MAP3K14 | 0.34582846 |
| 119 | CSNK1E | 0.33879624 |
| 120 | CSNK1G2 | 0.33497587 |
| 121 | CAMK4 | 0.32737111 |
| 122 | PRKD2 | 0.32483811 |
| 123 | PRKACB | 0.32481694 |
| 124 | CDK15 | 0.32473386 |
| 125 | NME1 | 0.32264799 |
| 126 | RET | 0.31664994 |
| 127 | CAMK2G | 0.30045339 |
| 128 | CDK14 | 0.30010980 |
| 129 | DYRK1A | 0.29247557 |
| 130 | MAP3K1 | 0.29117581 |
| 131 | PAK3 | 0.29044912 |
| 132 | PRKACA | 0.28245280 |
| 133 | CAMK2D | 0.27971295 |
| 134 | PHKG2 | 0.27342068 |
| 135 | PHKG1 | 0.27342068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.67323995 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 4.16174686 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.33331711 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.00771810 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.85008774 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.82394266 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.77194619 |
| 8 | Olfactory transduction_Homo sapiens_hsa04740 | 2.60425597 |
| 9 | Circadian entrainment_Homo sapiens_hsa04713 | 2.58061529 |
| 10 | Taste transduction_Homo sapiens_hsa04742 | 2.45510912 |
| 11 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.25449816 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.21007493 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 2.11741071 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.10033735 |
| 15 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.04055112 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 2.01262404 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.80393183 |
| 18 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.79685243 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.63170572 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.62627959 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.60863504 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.55855422 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.54524667 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.51114410 |
| 25 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.50760258 |
| 26 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.49032062 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.48963638 |
| 28 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.40974341 |
| 29 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.38216152 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.37071740 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.31515458 |
| 32 | Phototransduction_Homo sapiens_hsa04744 | 1.29162270 |
| 33 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.26922286 |
| 34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.24813401 |
| 35 | Long-term depression_Homo sapiens_hsa04730 | 1.24389792 |
| 36 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.23699241 |
| 37 | Protein export_Homo sapiens_hsa03060 | 1.21121710 |
| 38 | Circadian rhythm_Homo sapiens_hsa04710 | 1.15046264 |
| 39 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.12974676 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.11971467 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.09944392 |
| 42 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.07296963 |
| 43 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.07278666 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.04747477 |
| 45 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.03507785 |
| 46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.98511213 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.98407544 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.98093347 |
| 49 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.95026244 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.94907293 |
| 51 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.89277622 |
| 52 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.85037719 |
| 53 | Gap junction_Homo sapiens_hsa04540 | 0.83128142 |
| 54 | Axon guidance_Homo sapiens_hsa04360 | 0.82601215 |
| 55 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.81237595 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80226249 |
| 57 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.78671161 |
| 58 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.78539861 |
| 59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.77826916 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 0.77686138 |
| 61 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.76612137 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 0.73236540 |
| 63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72273140 |
| 64 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.71440548 |
| 65 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.70862520 |
| 66 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70416813 |
| 67 | Alzheimers disease_Homo sapiens_hsa05010 | 0.70137616 |
| 68 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68817442 |
| 69 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.68696110 |
| 70 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65257200 |
| 71 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64442692 |
| 72 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.64440414 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.63843689 |
| 74 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.62751897 |
| 75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.61892440 |
| 76 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61852612 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61109607 |
| 78 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60476153 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56905079 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.56237846 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.54279811 |
| 82 | Bile secretion_Homo sapiens_hsa04976 | 0.53221041 |
| 83 | Glioma_Homo sapiens_hsa05214 | 0.52362546 |
| 84 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52092970 |
| 85 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.50351840 |
| 86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.50229359 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.49064504 |
| 88 | Parkinsons disease_Homo sapiens_hsa05012 | 0.48684731 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46948895 |
| 90 | Mineral absorption_Homo sapiens_hsa04978 | 0.46118188 |
| 91 | Tuberculosis_Homo sapiens_hsa05152 | 0.45951786 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44637372 |
| 93 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.44609450 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43173823 |
| 95 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41632260 |
| 96 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.41038983 |
| 97 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.39753769 |
| 98 | Melanoma_Homo sapiens_hsa05218 | 0.37950326 |
| 99 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.36913579 |
| 100 | Allograft rejection_Homo sapiens_hsa05330 | 0.36323872 |
| 101 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.36104616 |
| 102 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.35446871 |
| 103 | Huntingtons disease_Homo sapiens_hsa05016 | 0.35192488 |
| 104 | Alcoholism_Homo sapiens_hsa05034 | 0.34960132 |
| 105 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.33252663 |
| 106 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.32978184 |
| 107 | Prion diseases_Homo sapiens_hsa05020 | 0.32729321 |
| 108 | Salmonella infection_Homo sapiens_hsa05132 | 0.32052853 |
| 109 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.32026986 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32019136 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31913129 |
| 112 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30633722 |
| 113 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.30212122 |
| 114 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.29826350 |
| 115 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28717743 |
| 116 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.27843334 |
| 117 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.27538460 |
| 118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.27023927 |
| 119 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.25661310 |
| 120 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.24624254 |
| 121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.24327877 |
| 122 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.22287269 |
| 123 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.22151069 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.21211339 |
| 125 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.21095464 |
| 126 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.19944263 |
| 127 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.19697679 |
| 128 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.18505832 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18308161 |

